Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nucleic Acids Res ; 49(11): 6529-6548, 2021 06 21.
Artículo en Inglés | MEDLINE | ID: mdl-34057470

RESUMEN

Post-transcriptional modification of tRNA wobble adenosine into inosine is crucial for decoding multiple mRNA codons by a single tRNA. The eukaryotic wobble adenosine-to-inosine modification is catalysed by the ADAT (ADAT2/ADAT3) complex that modifies up to eight tRNAs, requiring a full tRNA for activity. Yet, ADAT catalytic mechanism and its implication in neurodevelopmental disorders remain poorly understood. Here, we have characterized mouse ADAT and provide the molecular basis for tRNAs deamination by ADAT2 as well as ADAT3 inactivation by loss of catalytic and tRNA-binding determinants. We show that tRNA binding and deamination can vary depending on the cognate tRNA but absolutely rely on the eukaryote-specific ADAT3 N-terminal domain. This domain can rotate with respect to the ADAT catalytic domain to present and position the tRNA anticodon-stem-loop correctly in ADAT2 active site. A founder mutation in the ADAT3 N-terminal domain, which causes intellectual disability, does not affect tRNA binding despite the structural changes it induces but most likely hinders optimal presentation of the tRNA anticodon-stem-loop to ADAT2.


Asunto(s)
Adenosina Desaminasa/química , Adenosina/metabolismo , Adenosina Desaminasa/genética , Adenosina Desaminasa/metabolismo , Animales , Dominio Catalítico , Línea Celular Tumoral , Movimiento Celular , Cristalografía por Rayos X , Ferredoxinas/química , Inosina/metabolismo , Ratones , Modelos Moleculares , Mutación , Neuronas/fisiología , Dominios Proteicos , ARN de Transferencia/química , ARN de Transferencia/metabolismo
2.
J Hum Genet ; 67(12): 729-733, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36198761

RESUMEN

Kinesin Family Member 21B (KIF21B) encoded by KIF21B (MIM*608322), belongs to the Kinesin superfamily proteins, which play a key role in microtubule organisation in neuronal dendrites and axons. Recently, heterozygous variants in KIF21B were implicated as the cause of intellectual disability and brain malformations in four unrelated individuals. We report a 9-year-old male with delayed speech, hyperactivity, poor social interaction, and autistic features. A parent-offspring trio exome sequencing identified a novel de novo rare heterozygous variant, NM_001252102.2: c.1513A>C, p.(Ser505Arg) in exon 11 of KIF21B. In vivo functional analysis using in utero electroporation in mouse embryonic cortex revealed that the expression of Ser505Arg KIF21B protein in the cerebral cortex impaired the radial migration of projection neurons, thus confirming the pathogenicity of the variant. Our report further validates pathogenic variants in KIF21B as a cause of neurodevelopmental disorder.


Asunto(s)
Discapacidad Intelectual , Trastornos del Neurodesarrollo , Masculino , Animales , Ratones , Cinesinas/genética , Neuronas/metabolismo , Trastornos del Neurodesarrollo/genética , Trastornos del Neurodesarrollo/patología , Axones , Corteza Cerebral/patología , Discapacidad Intelectual/patología
3.
Hum Mol Genet ; 27(2): 224-238, 2018 01 15.
Artículo en Inglés | MEDLINE | ID: mdl-29077851

RESUMEN

Genetic findings reported by our group and others showed that de novo missense variants in the KIF2A gene underlie malformations of brain development called pachygyria and microcephaly. Though KIF2A is known as member of the Kinesin-13 family involved in the regulation of microtubule end dynamics through its ATP dependent MT-depolymerase activity, how KIF2A variants lead to brain malformations is still largely unknown. Using cellular and in utero electroporation approaches, we show here that KIF2A disease-causing variants disrupts projection neuron positioning and interneuron migration, as well as progenitors proliferation. Interestingly, further dissection of this latter process revealed that ciliogenesis regulation is also altered during progenitors cell cycle. Altogether, our data suggest that deregulation of the coupling between ciliogenesis and cell cycle might contribute to the pathogenesis of KIF2A-related brain malformations. They also raise the issue whether ciliogenesis defects are a hallmark of other brain malformations, such as those related to tubulins and MT-motor proteins variants.


Asunto(s)
Cilios/genética , Cinesinas/metabolismo , Malformaciones del Desarrollo Cortical/genética , Proteínas Represoras/metabolismo , Animales , Encéfalo/metabolismo , Ciclo Celular/genética , Cilios/fisiología , Células HeLa , Humanos , Cinesinas/genética , Malformaciones del Desarrollo Cortical/metabolismo , Ratones , Microcefalia/metabolismo , Microtúbulos/metabolismo , Neurogénesis , Proteínas Represoras/genética , Huso Acromático/metabolismo , Tubulina (Proteína)/metabolismo
4.
Proc Natl Acad Sci U S A ; 114(44): E9308-E9317, 2017 10 31.
Artículo en Inglés | MEDLINE | ID: mdl-29078390

RESUMEN

The family of WD40-repeat (WDR) proteins is one of the largest in eukaryotes, but little is known about their function in brain development. Among 26 WDR genes assessed, we found 7 displaying a major impact in neuronal morphology when inactivated in mice. Remarkably, all seven genes showed corpus callosum defects, including thicker (Atg16l1, Coro1c, Dmxl2, and Herc1), thinner (Kif21b and Wdr89), or absent corpus callosum (Wdr47), revealing a common role for WDR genes in brain connectivity. We focused on the poorly studied WDR47 protein sharing structural homology with LIS1, which causes lissencephaly. In a dosage-dependent manner, mice lacking Wdr47 showed lethality, extensive fiber defects, microcephaly, thinner cortices, and sensory motor gating abnormalities. We showed that WDR47 shares functional characteristics with LIS1 and participates in key microtubule-mediated processes, including neural stem cell proliferation, radial migration, and growth cone dynamics. In absence of WDR47, the exhaustion of late cortical progenitors and the consequent decrease of neurogenesis together with the impaired survival of late-born neurons are likely yielding to the worsening of the microcephaly phenotype postnatally. Interestingly, the WDR47-specific C-terminal to LisH (CTLH) domain was associated with functions in autophagy described in mammals. Silencing WDR47 in hypothalamic GT1-7 neuronal cells and yeast models independently recapitulated these findings, showing conserved mechanisms. Finally, our data identified superior cervical ganglion-10 (SCG10) as an interacting partner of WDR47. Taken together, these results provide a starting point for studying the implications of WDR proteins in neuronal regulation of microtubules and autophagy.


Asunto(s)
Autofagia/fisiología , Encéfalo/crecimiento & desarrollo , Encéfalo/metabolismo , Proteínas de Microfilamentos/metabolismo , Proteínas Asociadas a Microtúbulos/metabolismo , Repeticiones WD40/fisiología , Animales , Movimiento Celular/fisiología , Proliferación Celular/fisiología , Células Cultivadas , Femenino , Masculino , Ratones , Ratones Endogámicos C57BL , Microtúbulos/metabolismo , Microtúbulos/fisiología , Neurogénesis/fisiología , Neuronas/metabolismo , Neuronas/fisiología , Fenotipo , Células Madre/metabolismo , Células Madre/fisiología
5.
Prostaglandins Other Lipid Mediat ; 121(Pt A): 4-16, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26463849

RESUMEN

The prostanoid E2 (PGE2) is known to modulate the aggregative response of platelets to their conventional agonists such as ADP, TXA2, thrombin or collagen. Through the activation of its receptor EP3, PGE2 sensitizes platelets to their agonists but also inhibits them through its two other receptors, EP2 and EP4. In mice, the net result of these opposed actions is the EP3-mediated potentiation of platelet aggregation and the in vivo aggravation of murine atherothrombosis. Since the pathway PGE2/EP3 is not involved in murine hemostasis, we propose a "platelet EP3 paradigm" to describe this apparently paradoxical association between the facilitating impact on atherothrombosis and the unaltered hemostasis. Consistent with this paradigm, a drug blocking EP3 dramatically decreased atherothrombosis without inducing bleeding in mice. In humans, several studies did not agree on the effect of PGE2 on platelets. Reinterpreting these data with the notion of "potentiation window" and taking the platelet initial cAMP level into account reconciled these inconsistent results. Thereby, the in vitro potentiating effect of PGE2 on human platelets becomes clear. In addition, the EP3 blocking drug DG-041 abrogated the potentiating effect of PGE2 in whole human blood but did not prolong bleeding times in volunteers. Thus, the murine "platelet EP3 paradigm" would apply to humans if the aggravating role of PGE2 on atherothrombosis is shown in patients. Therefore, testing an EP3 blocker in a phase III trial would be of high interest to fulfill the unmet medical need which is to control atherothrombosis without impacting hemostasis and thus to improve the prevention of myocardial infarction.


Asunto(s)
Aterosclerosis/complicaciones , Dinoprostona/metabolismo , Hemorragia/inducido químicamente , Terapia Molecular Dirigida/métodos , Subtipo EP3 de Receptores de Prostaglandina E/metabolismo , Trombosis/complicaciones , Trombosis/prevención & control , Animales , Dinoprostona/biosíntesis , Humanos , Subtipo EP3 de Receptores de Prostaglandina E/antagonistas & inhibidores , Trombosis/metabolismo , Trombosis/fisiopatología
6.
medRxiv ; 2024 Mar 05.
Artículo en Inglés | MEDLINE | ID: mdl-38496416

RESUMEN

The ADAT2/ADAT3 complex catalyzes the adenosine to inosine modification at the wobble position of eukaryotic tRNAs. Mutations in ADAT3 , the catalytically inactive subunit of the ADAT2/ADAT3 complex, have been identified in patients presenting with severe neurodevelopmental disorders (NDDs). Yet, the physiological function of ADAT2/ADAT3 complex during brain development remains totally unknown. Here we showed that maintaining a proper level of ADAT2/ADAT3 catalytic activity is required for correct radial migration of projection neurons in the developing mouse cortex. In addition, we not only reported 7 new NDD patients carrying biallelic variants in ADAT3 but also deeply characterize the impact of those variants on ADAT2/ADAT3 structure, biochemical properties, enzymatic activity and tRNAs editing and abundance. We demonstrated that all the identified variants alter both the expression and the activity of the complex leading to a significant decrease of I 34 with direct consequence on their steady-state. Using in vivo complementation assays, we correlated the severity of the migration phenotype with the degree of the loss of function caused by the variants. Altogether, our results indicate a critical role of ADAT2/ADAT3 during cortical development and provide cellular and molecular insights into the pathogenicity of ADAT3-related neurodevelopmental disorder.

7.
J Exp Med ; 204(2): 311-20, 2007 Feb 19.
Artículo en Inglés | MEDLINE | ID: mdl-17242161

RESUMEN

Prostanoids, bioactive lipids derived from arachidonic acid (AA), are important for vascular homeostasis. Among them, prostaglandin E2 (PGE2) enhances aggregation of platelets submaximally stimulated in vitro. This results from activation of EP3, one of the four PGE2 receptors, which decreases the threshold at which agonists activate platelets to aggregate. Although PGE2 altered venous thrombosis induced by administration of AA, its role in pathophysiopathological conditions has remained speculative. We report that arterial walls subjected to inflammatory stimuli produce PGE2. In several models, we show that PGE2 produced by the arterial wall facilitates arterial thrombosis. Next, we detected PGE2 in mouse atherosclerotic plaques. We demonstrate that this plaque-produced PGE2 is not altered and is still able to activate EP3. In addition, we present evidence that PGE2 can leave the plaque and activate EP3 on blood platelets. Consistent with these findings, we observed that atherothrombosis induced in vivo by mechanical rupture of the plaque was drastically decreased when platelets lacked EP3. In conclusion, PGE2 facilitates the initiation of arterial thrombosis and, hence, contributes to atherothrombosis. Inhibition of the platelet EP3 receptor should improve prevention of atherothrombosis.


Asunto(s)
Arterias/inmunología , Aterosclerosis/inmunología , Plaquetas/metabolismo , Trombosis de las Arterias Carótidas/fisiopatología , Dinoprostona/metabolismo , Receptores de Prostaglandina E/metabolismo , Animales , Apolipoproteínas E/genética , Ácido Araquidónico/toxicidad , Arterias/metabolismo , Aterosclerosis/fisiopatología , Trombosis de las Arterias Carótidas/inducido químicamente , Técnicas para Inmunoenzimas , Ratones , Ratones Noqueados , Agregación Plaquetaria/inmunología , Receptores de Prostaglandina E/genética , Subtipo EP3 de Receptores de Prostaglandina E , Estadísticas no Paramétricas
8.
Cell Rep ; 42(7): 112744, 2023 07 25.
Artículo en Inglés | MEDLINE | ID: mdl-37418324

RESUMEN

Completion of neuronal migration is critical for brain development. Kif21b is a plus-end-directed kinesin motor protein that promotes intracellular transport and controls microtubule dynamics in neurons. Here we report a physiological function of Kif21b during radial migration of projection neurons in the mouse developing cortex. In vivo analysis in mouse and live imaging on cultured slices demonstrate that Kif21b regulates the radial glia-guided locomotion of newborn neurons independently of its motility on microtubules. We show that Kif21b directly binds and regulates the actin cytoskeleton both in vitro and in vivo in migratory neurons. We establish that Kif21b-mediated regulation of actin cytoskeleton dynamics influences branching and nucleokinesis during neuronal locomotion. Altogether, our results reveal atypical roles of Kif21b on the actin cytoskeleton during migration of cortical projection neurons.


Asunto(s)
Cinesinas , Neuronas , Animales , Ratones , Citoesqueleto de Actina/metabolismo , Movimiento Celular , Interneuronas/metabolismo , Cinesinas/metabolismo , Microtúbulos/metabolismo , Neuronas/metabolismo
9.
Nat Commun ; 11(1): 2441, 2020 05 15.
Artículo en Inglés | MEDLINE | ID: mdl-32415109

RESUMEN

KIF21B is a kinesin protein that promotes intracellular transport and controls microtubule dynamics. We report three missense variants and one duplication in KIF21B in individuals with neurodevelopmental disorders associated with brain malformations, including corpus callosum agenesis (ACC) and microcephaly. We demonstrate, in vivo, that the expression of KIF21B missense variants specifically recapitulates patients' neurodevelopmental abnormalities, including microcephaly and reduced intra- and inter-hemispheric connectivity. We establish that missense KIF21B variants impede neuronal migration through attenuation of kinesin autoinhibition leading to aberrant KIF21B motility activity. We also show that the ACC-related KIF21B variant independently perturbs axonal growth and ipsilateral axon branching through two distinct mechanisms, both leading to deregulation of canonical kinesin motor activity. The duplication introduces a premature termination codon leading to nonsense-mediated mRNA decay. Although we demonstrate that Kif21b haploinsufficiency leads to an impaired neuronal positioning, the duplication variant might not be pathogenic. Altogether, our data indicate that impaired KIF21B autoregulation and function play a critical role in the pathogenicity of human neurodevelopmental disorder.


Asunto(s)
Cinesinas/genética , Actividad Motora , Mutación/genética , Trastornos del Neurodesarrollo/genética , Trastornos del Neurodesarrollo/fisiopatología , Animales , Axones/metabolismo , Movimiento Celular , Proliferación Celular , Corteza Cerebral/embriología , Corteza Cerebral/patología , Corteza Cerebral/fisiopatología , Femenino , Regulación del Desarrollo de la Expresión Génica , Células HEK293 , Humanos , Masculino , Ratones , Mutación Missense/genética , Red Nerviosa/patología , Red Nerviosa/fisiopatología , Neuronas/metabolismo , Tamaño de los Órganos , Organogénesis/genética , Linaje , ARN Mensajero/genética , ARN Mensajero/metabolismo , Pez Cebra/anatomía & histología , Pez Cebra/genética
10.
Nat Commun ; 10(1): 2129, 2019 05 13.
Artículo en Inglés | MEDLINE | ID: mdl-31086189

RESUMEN

De novo heterozygous missense variants in the γ-tubulin gene TUBG1 have been linked to human malformations of cortical development associated with intellectual disability and epilepsy. Here, we investigated through in-utero electroporation and in-vivo studies, how four of these variants affect cortical development. We show that TUBG1 mutants affect neuronal positioning, disrupting the locomotion of new-born neurons but without affecting progenitors' proliferation. We further demonstrate that pathogenic TUBG1 variants are linked to reduced microtubule dynamics but without major structural nor functional centrosome defects in subject-derived fibroblasts. Additionally, we developed a knock-in Tubg1Y92C/+ mouse model and assessed consequences of the mutation. Although centrosomal positioning in bipolar neurons is correct, they fail to initiate locomotion. Furthermore, Tubg1Y92C/+ animals show neuroanatomical and behavioral defects and increased epileptic cortical activity. We show that Tubg1Y92C/+ mice partially mimic the human phenotype and therefore represent a relevant model for further investigations of the physiopathology of cortical malformations.


Asunto(s)
Malformaciones del Desarrollo Cortical/genética , Microtúbulos/metabolismo , Neurogénesis/genética , Neuronas/fisiología , Tubulina (Proteína)/genética , Animales , Conducta Animal , Movimiento Celular/genética , Centrosoma/metabolismo , Corteza Cerebral/anomalías , Corteza Cerebral/citología , Corteza Cerebral/diagnóstico por imagen , Modelos Animales de Enfermedad , Embrión de Mamíferos , Epilepsia/genética , Femenino , Fibroblastos/citología , Fibroblastos/metabolismo , Fibroblastos/ultraestructura , Técnicas de Sustitución del Gen , Predisposición Genética a la Enfermedad , Células HeLa , Humanos , Microscopía Intravital , Masculino , Ratones , Ratones Transgénicos , Microscopía Confocal , Microscopía Electrónica , Microtúbulos/genética , Mutación Missense
11.
Cardiovasc Res ; 114(12): 1656-1666, 2018 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-29800147

RESUMEN

Aims: Both leukotrienes and neutrophils have been linked to plaque destabilization. Despite being evoked, the role of leukotriene B4 (LTB4) in neutrophil recruitment to plaques and the concomitant effects of these two actors on plaque stability remain to be proven. Since both actors are elicited during endotoxaemia, a condition associated with the risk of cardiovascular events, we investigated whether endotoxaemia promotes LTB4-mediated neutrophil infiltration in plaques and explored the roles of LTB4 and neutrophils in plaque destabilization. Methods and results: Endotoxaemia induced by repeated peritoneal endotoxin injections at a non-lethal dose (1.5 mg/kg, 5 days) in chow-fed aged Apoe-/- mice (over 45 weeks old) resulted in neutrophil infiltration and activation in plaques. Subsequently to neutrophil invasion, plaques exhibited increased features of vulnerability: reduced collagen content, expanded necrotic cores, and thinned fibrous caps. These plaque features were reproduced by direct deposition of isolated neutrophils onto murine atheromatous carotid arteries in an in vivo assay. In endotoxemic mice, plaques produced increased amounts of LTB4. Genomic or pharmacological impairments of this production reduced neutrophil infiltration, collagenolysis, and apoptosis of smooth muscle cells in plaques of endotoxemic mice. Furthermore, conditioned media of human culprit plaques (CPs) contained more LTB4 than non-CPs and levels of LTB4 correlated to both neutrophil activation markers and endotoxin releases in CPs. Conclusion: These results show that the increased neutrophil recruitment elicited by LTB4 contributes to increase features of plaque destabilization in endotoxemic contexts and point out LTB4 as a potential therapeutic target in atherosclerosis.


Asunto(s)
Aorta/metabolismo , Enfermedades de la Aorta/metabolismo , Aterosclerosis/metabolismo , Endotoxemia/metabolismo , Leucotrieno B4/metabolismo , Activación Neutrófila , Infiltración Neutrófila , Neutrófilos/metabolismo , Placa Aterosclerótica , Animales , Aorta/patología , Enfermedades de la Aorta/genética , Enfermedades de la Aorta/patología , Araquidonato 5-Lipooxigenasa/genética , Araquidonato 5-Lipooxigenasa/metabolismo , Aterosclerosis/genética , Aterosclerosis/patología , Modelos Animales de Enfermedad , Endotoxemia/inducido químicamente , Endotoxemia/patología , Femenino , Fibrosis , Humanos , Lipopolisacáridos , Masculino , Ratones Endogámicos C57BL , Ratones Noqueados para ApoE , Necrosis , Comunicación Paracrina , Transducción de Señal , Técnicas de Cultivo de Tejidos
12.
Nat Genet ; 48(11): 1349-1358, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-27694961

RESUMEN

Neurodevelopmental disorders with periventricular nodular heterotopia (PNH) are etiologically heterogeneous, and their genetic causes remain in many cases unknown. Here we show that missense mutations in NEDD4L mapping to the HECT domain of the encoded E3 ubiquitin ligase lead to PNH associated with toe syndactyly, cleft palate and neurodevelopmental delay. Cellular and expression data showed sensitivity of PNH-associated mutants to proteasome degradation. Moreover, an in utero electroporation approach showed that PNH-related mutants and excess wild-type NEDD4L affect neurogenesis, neuronal positioning and terminal translocation. Further investigations, including rapamycin-based experiments, found differential deregulation of pathways involved. Excess wild-type NEDD4L leads to disruption of Dab1 and mTORC1 pathways, while PNH-related mutations are associated with deregulation of mTORC1 and AKT activities. Altogether, these data provide insights into the critical role of NEDD4L in the regulation of mTOR pathways and their contributions in cortical development.


Asunto(s)
Complejos de Clasificación Endosomal Requeridos para el Transporte/genética , Mutación Missense , Heterotopia Nodular Periventricular/genética , Ubiquitina-Proteína Ligasas/genética , Animales , Células Cultivadas , Femenino , Humanos , Masculino , Ratones , Ubiquitina-Proteína Ligasas Nedd4 , Dominios Proteicos/genética , Proteínas Proto-Oncogénicas c-akt/metabolismo , Transducción de Señal , Serina-Treonina Quinasas TOR/metabolismo , Ubiquitina/metabolismo
13.
Cardiovasc Res ; 101(3): 482-91, 2014 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-24323317

RESUMEN

AIMS: Haemostasis interrupts bleeding from disrupted blood vessels by activating platelet aggregation and coagulation. A similar mechanism termed thrombosis generates obstructive thrombi inside diseased arteries. As a consequence of this similarity, current anti-thrombotic agents increase the risk of bleeding. Atherosclerotic plaques produce significant amounts of prostaglandin E2 (PGE2), which activates its receptor EP3 on platelets and aggravates atherothrombosis. We investigated whether blocking EP3 could dissociate atherothrombosis from haemostasis. METHODS AND RESULTS: Inhibiting in vivo the receptor EP3 for PGE2 with the blocking agent DG-041 reduced murine thrombosis triggered by local delivery of arachidonic acid or ferric chloride on healthy arteries. Importantly, it also reduced thrombosis triggered by scratching murine atherosclerotic plaques. PGE2 was not produced at the bleeding site after tail clipping. Consistently, blocking EP3 did not alter murine tail, liver, or cerebral haemostasis. Furthermore, blocking EP3 reduced murine pulmonary embolism and intensified platelet inhibition by clopidogrel leaving tail bleeding times unchanged. Human atherosclerotic plaques produced PGE2, which facilitated platelet aggregation in human blood and rescued the function of P2Y12-blocked platelets. Finally, in healthy patients, DG-041 reduced platelet aggregation, but did not significantly alter the cutaneous bleeding time at doses up to eight times the dose that inhibited the facilitating effect of PGE2 on platelets. CONCLUSION: In mice, blocking EP3 inhibited atherothrombosis without affecting haemostasis and intensified efficiency of conventional anti-platelet treatment without aggravating the bleeding risk. In patients, blocking EP3 should improve the prevention of cardiovascular diseases, which is currently limited by the risk of bleeding.


Asunto(s)
Acrilamidas/farmacología , Dinoprostona/metabolismo , Inhibidores de Agregación Plaquetaria/farmacología , Subtipo EP3 de Receptores de Prostaglandina E/antagonistas & inhibidores , Sulfonas/farmacología , Trombosis/tratamiento farmacológico , Animales , Plaquetas/efectos de los fármacos , Clopidogrel , Modelos Animales de Enfermedad , Ratones , Placa Aterosclerótica/tratamiento farmacológico , Placa Aterosclerótica/metabolismo , Agregación Plaquetaria/efectos de los fármacos , Agregación Plaquetaria/fisiología , Trombosis/metabolismo , Ticlopidina/análogos & derivados , Ticlopidina/farmacología
14.
J Periodontol ; 84(3): 396-406, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22655910

RESUMEN

BACKGROUND: The great variability of periodontal and systemic responses to experimental periodontitis reflects the inherent pathogenic complexity of mice models and could limit the resulting interpretations and their extension to human diseases. This study compared the effect of Porphyromonas gingivalis (Pg) infection and experimental periodontitis duration at local and systemic levels in various models. METHODS: Periodontitis was induced in C57BL/6J mice by ligatures previously incubated with Pg (LIGPG group) or not (LIG group) or by oral gavage (GAV) with Pg ATCC 33277. Blood samples were taken, and mice were euthanized at different times. Periodontal tissue destruction, osteoclast number, and inflammation were assessed by histomorphometry, tartrate-resistant acid phosphatase histoenzymology, and cathepsin B (CATB) and matrix metalloproteinase 9 (MMP9) immunochemistry. Serum levels of interleukin-6 (IL-6) and IL-1ß were measured using enzyme-linked immunosorbent assay bioplex methods. RESULTS: Periodontal tissue destruction and osteoclast numbers were significantly elevated in LIGPG models compared to LIG and GAV models. They increased with time with the exception of osteoclast numbers in the LIG model. CATB and MMP9 expression was related to bone destruction processes and Pg infection. The highest serum levels of IL-6 and IL-1ß were observed in the LIGPG group. A decrease of IL-6 and an increase of IL-1ß serum level were observed with time in LIGPG group contrary to LIG group. CONCLUSIONS: These data indicate that Pg infection worsened periodontal tissue destruction through specific pathogenic pathways and modified systemic response to periodontal inflammation. Furthermore, the blood cytokine response to ligature models showed their relevance for evaluating the systemic impact of periodontal disease.


Asunto(s)
Modelos Animales de Enfermedad , Inflamación/fisiopatología , Periodontitis/enzimología , Periodontitis/microbiología , Porphyromonas gingivalis/fisiología , Pérdida de Hueso Alveolar/metabolismo , Pérdida de Hueso Alveolar/patología , Animales , Catepsina B/metabolismo , Lavado Gástrico , Interleucina-1beta/sangre , Interleucina-6/sangre , Ligadura , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Ratones Endogámicos C57BL , Osteoclastos/patología , Periodontitis/patología , Factores de Tiempo , Virulencia
15.
J Lipid Res ; 44(2): 430-6, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12576526

RESUMEN

Apolipoprotein C-III (apoC-III) is involved in triglycerides metabolism, and is therefore important for the pathogenesis of coronary heart diseases. However, to our knowledge serum apoC-III variation factors and reference limits have never been determined, so the aim of this study was to establish them and facilitate clinical usefulness. We measured serum apoC-III concentration of apparently healthy subjects of the Stanislas Cohort by an immunoturbidimetric method. Genetic polymorphisms within the APOC3, APOE, APOAIV, and LPL genes were determined by a multiplex PCR. Serum apoC-III concentration varied from 28.2 mg/l to 225.8 mg/l in the overall sample and between subjects variability was about 30%. Factors influencing apoC-III concentration were age, BMI in adult men, alcohol consumption in adults, oral contraceptive intake in women, the post-pubescent status in boys. The APOC3 1100T allele in adult men and the APOC3 -455C allele in boys were associated with increased apoC-III concentration. The APOA4 360His allele was associated with decreased apoC-III concentration in women. We also established reference limits of serum apoC-III concentration according to age and gender.


Asunto(s)
Apolipoproteínas C/sangre , Apolipoproteínas C/genética , Adolescente , Adulto , Apolipoproteína C-III , Niño , Preescolar , Estudios de Cohortes , Femenino , Francia , Humanos , Masculino , Persona de Mediana Edad , Polimorfismo Genético , Valores de Referencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA